Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
Archives of Internal Medicine
doi 10.1001/archinte.160.19.2998
Full Text
Open PDFAbstract
Available in full text
Date
October 23, 2000
Authors
Publisher
American Medical Association (AMA)